Association of glucagon ‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

ConclusionGLP-1RA treatment is associated with gastric residue in an esophagogastroduodenoscopy in patients with diabetes.

Source: Journal of Diabetes Investigation - March 16, 2023 Category: Endocrinology Authors: Toshiko Kobori, Yukiko Onishi, Yoko Yoshida, Tazu Tahara, Takako Kikuchi, Tetsuya Kubota, Masahiko Iwamoto, Tomonobu Sawada, Reo Kobayashi, Hiroaki Fujiwara, Masato Kasuga Tags: Original Article Source Type: research